LivaNova PLC

LivaNova PLC is a global medical technology company dedicated to improving patient outcomes through innovative solutions for cardiovascular and neurological conditions. The company operates through two distinct segments: Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment offers a comprehensive suite of products essential for open-heart surgery, including heart-lung machines, oxygenators, autotransfusion systems, and various perfusion accessories designed to support patients undergoing complex cardiac procedures. In the Neuromodulation segment, LivaNova provides the VNS Therapy System, an implantable device that stimulates the vagus nerve to treat challenging conditions such as drug-resistant epilepsy and difficult-to-treat depression. This therapy represents a significant advancement in non-pharmacological treatment options. LivaNova's products are utilized by a range of healthcare professionals, including perfusionists, neurologists, and neurosurgeons, serving hospitals and medical institutions globally. The company employs a multi-channel distribution strategy, leveraging a direct sales force, agents, and independent distributors to reach its diverse customer base across international markets. This dual focus on critical care and advanced neurological therapies positions LivaNova as a key player in specialized medical device markets.